Cellular and Molecular Mechanisms Underlie the Anti-Tumor Activities Exerted by Walterinnesia aegyptia Venom Combined with Silica Nanoparticles against Multiple Myeloma Cancer Cell Types

被引:18
作者
Badr, Gamal [1 ,2 ]
Al-Sadoon, Mohamed K. [3 ]
Abdel-Maksoud, Mostafa A. [3 ]
Rabah, Danny M. [1 ,4 ]
El-Toni, Ahmed M. [5 ,6 ]
机构
[1] King Saud Univ, Coll Med, Princess Johara Alibrahim Ctr Canc Res, Prostate Canc Res Chair, Riyadh 11461, Saudi Arabia
[2] Assiut Univ, Fac Sci, Dept Zool, Immunol & Mol Biol Lab, Assiut, Egypt
[3] King Saud Univ, Coll Sci, Dept Zool, Riyadh 11461, Saudi Arabia
[4] King Saud Univ, Coll Med, Dept Urol Surg, Riyadh 11461, Saudi Arabia
[5] King Saud Univ, King Abdullah Inst Nanotechnol, Riyadh 11461, Saudi Arabia
[6] CMRDI, Helwan, Egypt
关键词
VIPERA-LEBETINA-TURANICA; CHEMOKINE RECEPTORS; IN-VIVO; KAPPA-B; APOPTOSIS; GROWTH; INDUCTION; TOXIN; THERAPY; CXCR4;
D O I
10.1371/journal.pone.0051661
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Multiple myeloma (MM) is a clonal disease of plasma cells that remains incurable despite the advent of several novel therapeutics. In this study, we aimed to delineate the impact of snake venom extracted from Walterinnesia aegyptia (WEV) alone or in combination with silica nanoparticles (WEV+NP) on primary MM cells isolated from patients diagnosed with MM as well as on two MM cell lines, U266 and RPMI 8226. The IC50 values of WEV and WEV+NP that significantly decreased MM cell viability without affecting the viability of normal peripheral mononuclear cells (PBMCs) were determined to be 25 ng/ml and 10 ng/ml, respectively. Although both WEV (25 ng/ml) and WEV+NP (10 ng/ml) decreased the CD54 surface expression without affecting the expression of CXCR4 (CXCL12 receptor) on MM cells, they significantly reduced the ability of CXC chemokine ligand 12 (CXCL12) to induce actin cytoskeleton rearrangement and the subsequent reduction in chemotaxis. It has been established that the binding of CXCL12 to its receptor CXCR4 activates multiple intracellular signal transduction pathways that regulate MM cell chemotaxis, adhesion, and proliferation. We found that WEV and WEV+NP clearly decreased the CXCL12/CXCR4-mediated activation of AKT, ERK, NF kappa B and Rho-A using western blot analysis; abrogated the CXCL12-mediated proliferation of MM cells using the CFSE assay; and induced apoptosis in MM cell as determined by PI/annexin V double staining followed by flow cytometry analysis. Monitoring the expression of B-cell CCL/Lymphoma 2 (Bcl-2) family members and their role in apoptosis induction after treatment with WEV or WEV+NP revealed that the combination of WEV with NP robustly decreased the expression of the anti-apoptotic effectors Bcl-2, Bcl(XL) and Mcl-1; conversely increased the expression of the pro-apoptotic effectors Bak, Bax and Bim; and altered the mitochondrial membrane potential in MM cells. Taken together, our data reveal the biological effects of WEV and WEV+NP and the underlying mechanisms against myeloma cancer cells.
引用
收藏
页数:15
相关论文
共 57 条
[21]   Nanocarriers' entry into the cell: relevance to drug delivery [J].
Hillaireau, Herve ;
Couvreur, Patrick .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2009, 66 (17) :2873-2896
[22]   Derivative (1;7)(q10;p10) in multiple myeloma. A sign of therapy-related hidden myelodysplastic syndrome [J].
Ishii, Yuko ;
Hsiao, Hui-Hua ;
Sashida, Goro ;
Ioa, Yoshikazu ;
Miyazawa, Keisuke ;
Kodama, Atsushi ;
Ohyashiki, Junko H. ;
Ohyashiki, Kazuma .
CANCER GENETICS AND CYTOGENETICS, 2006, 167 (02) :131-137
[23]   Chemokine-dependent B cell-T cell interactions in chronic lymphocytic leukemia and multiple myeloma - targets for therapeutic intervention? [J].
Joehrer, Karin ;
Hofbauer, Sebastian W. ;
Zelle-Rieser, Claudia ;
Greil, Richard ;
Hartmann, Tanja N. .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (04) :425-441
[24]   In Vivo Targeted Delivery of Nanoparticles for Theranosis [J].
Koo, Heebeom ;
Huh, Myung Sook ;
Sun, In-Cheol ;
Yuk, Soon Hong ;
Choi, Kuiwon ;
Kim, Kwangmeyung ;
Kwon, Ick Chan .
ACCOUNTS OF CHEMICAL RESEARCH, 2011, 44 (10) :1018-1028
[25]   Temperature-Sensitive Polymer-Coated Magnetic Nanoparticles as a Potential Drug Delivery System for Targeted Therapy of Thyroid Cancer [J].
Koppolu, Bhanuprasanth ;
Bhavsar, Zarna ;
Wadajkar, Aniket S. ;
Nattama, Sivaniarvindpriya ;
Rahimi, Maham ;
Nwariaku, Fiemu ;
Nguyen, Kytai T. .
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2012, 8 (06) :983-990
[26]   The Role of Bcl-2 Family Proteins in Therapy Responses of Malignant Astrocytic Gliomas: Bcl2L12 and Beyond [J].
Kouri, Fotini M. ;
Jensen, Samuel A. ;
Stegh, Alexander H. .
SCIENTIFIC WORLD JOURNAL, 2012, :1-8
[27]   Liposomes and nanotechnology in drug development: focus on oncotargets [J].
Kozako, Tomohiro ;
Arima, Naomichi ;
Yoshimitsu, Makoto ;
Honda, Shin-Ichro ;
Soeda, Shinji .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2012, 7 :4943-4951
[28]   Antioxidants and cancer therapy: A systematic review [J].
Ladas, EJ ;
Jacobson, JS ;
Kennedy, DD ;
Teel, K ;
Fleischauer, A ;
Kelly, KM .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (03) :517-528
[29]   An Aqueous Extract of Fagonia cretica Induces DNA Damage, Cell Cycle Arrest and Apoptosis in Breast Cancer Cells via FOXO3a and p53 Expression [J].
Lam, Matt ;
Carmichael, Amtul R. ;
Griffiths, Helen R. .
PLOS ONE, 2012, 7 (06)
[30]   Improved biological half-life and anti-tumor activity of TNF-related apoptosis-inducing ligand (TRAIL) using PEG-exposed nanoparticles [J].
Lim, Sung Mook ;
Kim, Tae Hyung ;
Jiang, Hai Hua ;
Park, Chan Woong ;
Lee, Seulki ;
Chen, Xiaoyuan ;
Lee, Kang Choon .
BIOMATERIALS, 2011, 32 (13) :3538-3546